Findings point to earlier, smarter, and more personalised care
EASD 2025: New frontiers in diabetes care revealedAnnual meeting reveals first EASD guideline on diabetes distress, semaglutide, CagriSema, combination therapies, and CVD advances in diabetes care.
> Read more